Compare Vaxcyte Inc. Common Stock (PCVX) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Rockwell Automation — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.63B), while Rockwell Automation trades at $419.62 (market cap $47.02B). The key difference: Rockwell Automation is far larger — about 4.4× Vaxcyte Inc. Common Stock's market cap, and Rockwell Automation pays a 1.3% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Rockwell Automation for 74 Days on average.
| PCVX | ROK | |
|---|---|---|
Market Cap | $10.63B | $47.02B |
Volume | 1,525,205 | 690,030 |
Sector | Health | Industrials |
52-Week High | $73.82 | $495.08 |
52-Week Low | $40.32 | $347.66 |
Typical Hold Time | 0 Days | 74 Days |
Enterprise Value | $9.26B | $50.15B |
Dividend Yield | — | 1.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rockwell Automation (ROK) trades at $432.29, down 0.39% on the day, with a bearish technical signal and mixed sentiment. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but valuation ratios are elevated with a P/E of 39.65. Recent earnings have consistently beaten estimates, and the company maintains leadership in industrial automation, supported by positive industry trends like digital transformation and AI adoption.
The outlook is cautiously optimistic given ROK's market position and earnings momentum, but high valuation and macroeconomic risks pose challenges. Upside exists if the company meets Q3 2026 EPS expectations of $3.69, with a consensus price target of $489.89 suggesting potential appreciation. Key risks include competitive pressures, economic sensitivity, and execution hurdles in sustaining growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
